African Pharmaceutical Regulatory Intelligence
OXALIPLATIN
64 registrations across 8 African markets— 45 active
Markets with OXALIPLATIN
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| OXALIGAL 50 SOLUTION; INJECTION | 🇿🇼Zimbabwe | RHAEGAL PHARMACEUTICALS | active | May 2031 |
| OXALIGAL 100 SOLUTION; INFUSION | 🇿🇼Zimbabwe | RHAEGAL PHARMACEUTICALS | active | May 2031 |
| OXALICAN 200 SOLUTION; INJECTION | 🇿🇼Zimbabwe | RHAEGAL PHARMACEUTICALS | active | Apr 2031 |
| OXALICAN 50 SOLUTION; INJECTION | 🇿🇼Zimbabwe | RHAEGAL PHARMACEUTICALS | active | Apr 2031 |
| OXALIPLATIN 5MG/ML solution for infusion Concentrate for solution for infusion | 🇷🇼Rwanda | HERAEUS MEDICAL GMBH | active | Feb 2031 |
| OXOL SOLUTION; INJECTION | 🇿🇼Zimbabwe | VENUS REMEDIES LTD | active | Sept 2030 |
| OXALITHER 50 Concentrate For Solution For Infusion | 🇰🇪Kenya | TherDose Pharma Private Limited | active | Jan 2030 |
| OXALITHER 100 Concentrate For Solution For Infusion | 🇰🇪Kenya | TherDose Pharma Private Limited | active | Jan 2030 |
| VSI Oxaliplatin Injection Injection | 🇳🇬Nigeria | Manola Pharmaceuticals Limited | active | Aug 2029 |
| OXALIPLATIN INJECTION | 🇬🇭Ghana | — | active | Jun 2029 |
| OXALIPLATIN INJECTION (Each 20ml contains Oxaliplatin 100mg/20ml) | 🇬🇭Ghana | — | active | Jun 2029 |
| OXALIPLATIN INJECTION | 🇬🇭Ghana | — | active | Jun 2029 |
| OXALIPLATIN INJECTION (Each 20ml contains Oxaliplatin 100mg/20ml) | 🇬🇭Ghana | — | active | Jun 2029 |
| OXALILIVE 100 Solution For Injection | 🇰🇪Kenya | Sofita Pharmaceutical Wholesalers Limited | active | Mar 2029 |
| OXOL INJECTABLE; INJECTION | 🇿🇼Zimbabwe | VENUS REMEDIES LTD | active | Feb 2029 |
| OXITAN Injection Concentrate Concentrate For Solution For Infusion | 🇰🇪Kenya | Fresenius Kabi South Africa (Pty) Limited | active | Mar 2028 |
| RECOTAXIN 200 mg/40 ml | 🇿🇦South Africa | Aurogen South Africa (Pty) Ltd | active | Dec 2027 |
| XILAZ 50 mg/10 ml | 🇿🇦South Africa | Aurogen South Africa (Pty) Ltd | active | Dec 2027 |
| XILAZ 100 mg/20 ml | 🇿🇦South Africa | Aurogen South Africa (Pty) Ltd | active | Dec 2027 |
| RECOTAXIN 100 mg/20 ml | 🇿🇦South Africa | Aurogen South Africa (Pty) Ltd | active | Dec 2027 |
| RECOTAXIN 50 mg/10 ml | 🇿🇦South Africa | Aurogen South Africa (Pty) Ltd | active | Dec 2027 |
| Oxaliplatin Sandoz Concentrate For Solution For Infusion Solution for injection/infusion | 🇳🇬Nigeria | Novartis Nigeria Limited | active | Oct 2027 |
| Eloxatin Infusion Solution for infusion | 🇳🇬Nigeria | Sanofi-Aventis Nigeria Limited | active | Aug 2026 |
| Celdach 100 Injection** Powder for infusion | 🇳🇬Nigeria | L'PaceMaker Pharmaceuticals Limited | active | Jun 2026 |
| OXALIPLATIN 100 CIPLA | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | suspended | Jul 2025 |
| OXALIPLATIN MEDPRO 50 | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | suspended | Jul 2025 |
| OXALIPLATIN MEDPRO 100 | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | suspended | Jul 2025 |
| OXALIPLATIN 50 CIPLA | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | suspended | Jul 2025 |
| OXALIWIN 50 mg/10 ml RTU | 🇿🇦South Africa | Sanofi-Aventis South Africa (Pty) Ltd | suspended | May 2025 |
| OXALIPLATIN KEY 50 | 🇿🇦South Africa | Key Oncologics (Pty) Ltd | suspended | May 2025 |
| OXALIWIN 100 mg/20 ml RTU | 🇿🇦South Africa | Sanofi-Aventis South Africa (Pty) Ltd | suspended | May 2025 |
| OXLIPLATIN KEY 100 | 🇿🇦South Africa | Key Oncologics (Pty) Ltd | suspended | May 2025 |
| GOXYRAL 100 | 🇿🇦South Africa | Pharmaplan (Pty) Ltd | suspended | Mar 2025 |
| GOXYRAL 50 | 🇿🇦South Africa | Pharmaplan (Pty) Ltd | suspended | Mar 2025 |
| OXAVIATIN 200 mg/40 ml | 🇿🇦South Africa | Safeline Pharmaceuticals (Pty) Ltd | suspended | Nov 2023 |
| OXAVIATIN 100 mg/20 ml | 🇿🇦South Africa | Safeline Pharmaceuticals (Pty) Ltd | suspended | Nov 2023 |
| OXAVIATIN 50 mg/10 ml | 🇿🇦South Africa | Safeline Pharmaceuticals (Pty) Ltd | suspended | Nov 2023 |
| ELOXATIN 100 mg/20 ml | 🇿🇦South Africa | Sanofi-Aventis South Africa (Pty) Ltd | suspended | Jul 2023 |
| OXALIWIN 50 mg/10 ml | 🇿🇦South Africa | Sanofi-Aventis South Africa (Pty) Ltd | suspended | Jul 2023 |
| OXALIWIN 100 mg/20 ml | 🇿🇦South Africa | Sanofi-Aventis South Africa (Pty) Ltd | suspended | Jul 2023 |
| OXALIPLATIN SANDOZ 5MG/ML POWDER FOR SOLUTION FOR INFUSION/ 1 X 1 VIAL | 🇳🇬Nigeria | NORVATIS NIG. LTD. MANSARD PLACE | expired | Jul 2022 |
| OXALIPLATIN "EBEWE" 50 mg | 🇿🇦South Africa | Sandoz South Africa (Pty) Ltd | suspended | Jan 2022 |
| OXALIPLATIN "EBEWE" 100 mg | 🇿🇦South Africa | Sandoz South Africa (Pty) Ltd | suspended | Jan 2022 |
| ELOPLAT 150 | 🇿🇦South Africa | Sandoz South Africa (Pty) Ltd | active | Jan 1900 |
| ELOPLAT 50 | 🇿🇦South Africa | Sandoz South Africa (Pty) Ltd | active | Jan 1900 |
| ELOPLAT 100 | 🇿🇦South Africa | Sandoz South Africa (Pty) Ltd | active | Jan 1900 |
| INTAS-OXALIPLATIN 50 | 🇿🇦South Africa | Eurolab (Pty) Ltd | active | Jan 1900 |
| OXALIPLATIN PCH 50 | 🇿🇦South Africa | Teva Pharmaceuticals (Pty) Ltd | active | Jan 1900 |
| OXALIPLATIN PCH 100 | 🇿🇦South Africa | Teva Pharmaceuticals (Pty) Ltd | active | Jan 1900 |
| ELOPLAT 200 | 🇿🇦South Africa | Sandoz South Africa (Pty) Ltd | active | Jan 1900 |
Showing 50 of 64 registrations. Sign up free to search and export all.
OXALIPLATIN in Africa — Regulatory Overview
OXALIPLATIN is registered across 8 African markets with 64 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Zimbabwe, Tanzania, Nigeria and 4 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 64 registrations, 45 (70%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.